Eyenuk, Inc.

📍 Los Angeles, United States🗓 Founded 2010👥 28 employees💰 Last funded Oct 2019
Medical Device🌐 eyenuk.com
Website LinkedIn
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Eyenuk, Inc.?
Eyenuk, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Eyenuk, Inc. last raise funding?
The most recent investment in Eyenuk, Inc. recorded on gritt.io was in October 2019.
When was Eyenuk, Inc. founded?
Eyenuk, Inc. was founded in 2010.
What industry is Eyenuk, Inc. in?
Eyenuk, Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Eyenuk, Inc. based?
Eyenuk, Inc. is headquartered in Los Angeles, United States.